Back to News
Market Impact: 0.15

August 2026 Options Now Available For UiPath (PATH)

PATH
Futures & OptionsDerivatives & VolatilityMarket Technicals & FlowsInvestor Sentiment & PositioningCompany Fundamentals
August 2026 Options Now Available For UiPath (PATH)

UiPath (PATH) is trading at $16.10; selling the $13.00 put (bid $1.23) commits purchase at $13.00 but nets a cost basis of $11.77 and is ~19% below current price, with analytics putting the probability of the put expiring worthless at 77% and a cash-return (YieldBoost) of 9.46% (14.04% annualized). Alternatively, selling the $24.00 covered call (bid $0.99) against shares bought at $16.10 yields a potential total return of 55.22% if assigned at Aug 2026, or a 6.15% premium boost (9.13% annualized) with a 67% chance of expiring worthless. Implied volatilities are ~61% (put) and 65% (call), versus a trailing 12-month volatility of 59%, highlighting elevated option premia for income-oriented strategies.

Analysis

Market structure: Option flow favors income sellers — cash‑secured put sellers at PATH $13 (collect $1.23 -> effective cost $11.77, ~27% below $16.10) or buy‑write at $24 cap offer attractive yield boosts (9.46% / 14.04% annualized for the put; 6.15% / 9.13% annualized for the call). With implied vol 61–65% vs realized ~59%, the market is pricing modest premium but not panic; probabilities shown (77% put expires OTM, 67% call OTM) imply tail risk priced but not overstated. Winners: options sellers, long-term buy‑and‑hold opportunists; losers: liquidity providers if IV spikes, and long convexity traders if IV collapses. Risk assessment: Tail risks include major execution slowdown in RPA/automation demand, enterprise wallet reallocation to hyperscalers (Microsoft/Google), or a revenue miss that forces guidance cut — each could drop PATH >40% in a quarter. Near term (days–weeks) option sellers face IV and earnings risk; short term (3–12 months) macro and AI adoption cadence drives direction; long term (2+ years) depends on ARR growth and margin expansion. Hidden dependency: option liquidity and skew can shift quickly on event flow, creating assignment risk or jagged fills. Trade implications: Primary trade for income: establish a 1–3% portfolio cash‑secured put position selling PATH Aug‑2026 $13 put for $1.23, size so max obligation <= 3% equity and prefer a $13/$10 bull‑put spread to cap downside (max loss = $3 - net credit). Secondary: buy 1–2% position in PATH and sell Aug‑2026 $24 covered call (collect $0.99) to lock 55% upside while funding basis; if bullish on re‑rating, instead buy stock and buy OTM calls as leverage. Avoid writing naked near‑term options within 7–14 days of earnings and trim if IV collapses <45%. Contrarian angles: Consensus treats PATH as a mid‑vol income candidate; what's missed is adoption runway versus enterprise substitutes — if PATH reports 20%+ ARR growth acceleration next two quarters, equity could rerate 2x quickly, making covered calls costly. Conversely, if IV compresses from 65% to realized 40% without a fundamentals hit, short put sellers lock easy alpha; watch open interest and put/call skew for early signs. Historical parallel: mid‑cycle SaaS re‑rating episodes show rapid 30–60% moves on guidance beats/misses — position sizing and defined risk are critical.